Wednesday June 29, 2022
Blue Magazine Logo
Let's you read the sky

Bioanalytical Testing Services: High Quality Analytical Services with the Most Cutting Edge Technology!

 Bioanalytical Testing Services: High Quality Analytical Services with the Most Cutting Edge Technology!

Bioanalytical Testing Services Market

Bioanalytical testing services provide the most advanced technology available to help you optimize processes, protect product quality and achieve your performance goals. These tests provide you with accurate, reliable and convenient bioanalytical testing services to support pre-clinical and Phase I through Phase IV clinical trials.

Global bioanalytical testing services market will reach $7,902.9 million by 2031, growing by 9.1% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.

Highlighted with 88 tables and 111 figures, this 193-page report “Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global bioanalytical testing services market and all its sub-segments through extensively detailed classifications.

Download Report Sample with Latest Industry Insights @ https://altusmarketresearch.com/reports/sample/29918

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global Bioanalytical Testing Services Market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Region.

Test Type:

• Cell-based Assays

o Bacterial Cell-based Assays
o Viral Cell-based Assays

• Virology Testing

o In Vitro Virology Testing
o In Vivo Virology Testing
o Species-Specific Viral PCR Assays

• Serology, Immunogenicity, and Neutralizing Antibodies (SINA)

o Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
o Viral Serology, Immunogenicity, and Neutralizing Antibodies

• Method Development Optimization and Validation (MDOV)
• Biomarker Testing
• Pharmacokinetic Testing

By Workflow Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Sample Preparation
o Protein Precipitation
o Liquid-liquid Extraction (LLE)
• Sample Analysis
o Hyphenated Technique
o Chromatographic Technique
o Electrophoresis
o Ligand Binding Assay
o Mass Spectrometry
o Nuclear Magnetic Resonance
• Other Workflow Processes

Key Players:

Charles River Laboratories International Inc. | Covance Inc. | Eurofins Scientific | ICON PLC | Intertek Group PLC | IQVIA Holdings, Inc. | Laboratory Corporation of America Holdings | Medpace Holdings, Inc. | Pace Analytical Services LLC. | Parexel International Corporation | PPD Inc. | SGS SA | Syneos Health, LLC | Toxikon Corporation | WuXi Apptech Co., Ltd.

By Therapeutic Area, the global Bioanalytical Testing Services Market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Therapeutic Areas

By End User, the global Bioanalytical Testing Services Market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Pharma and Biopharma Companies
• Contract Development and Manufacturing Organizations (CDMOs)
• Contract Research Organizations (CROs)

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included.

AmyAMR

http://altusmarketresearch.com/

A Businesswoman having more than 20 years of experience in the finance sector, working as a chief growth strategist at Altus Market Research

Leave a Reply

Your email address will not be published.

Related post